IMA · ISSUER CIK 1835579
ImageneBio, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 ImageneBio, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 17, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 202617:00 | Aug 14, 2026 | IMA | Chief Executive Officer, Director | A · Grant | — | +254,800 | 493,705 | +107% | — | ||
| Aug 17, 202617:00 | Aug 14, 2026 | IMA | Chief Financial Officer | A · Grant | — | +104,000 | 104,000 | New | — |